40 results
SC 13D/A
EX-4
1315 Capital II, L.P.
20 May 21
INTERPACE BIOSCIENCES / 1315 Capital II ownership change
12:00am
8-K
EX-4.3
txucpso qyy2uwk4u
23 Oct 20
Entry into a Material Definitive Agreement
4:01pm
S-8
EX-4.4
7mc ez47s7zv
21 Oct 19
Registration of securities for employees
7:41pm
S-8
EX-4.3
0abp654q3o8umphmcc4
21 Oct 19
Registration of securities for employees
7:41pm
S-8 POS
EX-4.3
6sotco
21 Oct 19
Registration of securities for employees (post-effective amendment)
7:34pm
S-8 POS
EX-4.4
lixdzvxsexdq7bwh2il
21 Oct 19
Registration of securities for employees (post-effective amendment)
7:34pm
8-K
EX-4.1
nizb le7si3jg1bxzli3
19 Jul 19
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
5:03pm
8-K
EX-4.1
mbti7g9mm4
28 Jan 19
Interpace Diagnostics Announces Proposed Public Offering of Common Stock
9:40pm